Skip to main content
. 2019 Jun 21;11(6):1407. doi: 10.3390/nu11061407

Table 1.

Patient characteristics, body composition, biochemical parameters at baseline.

Variables Total (N = 370) Survival (N = 325) Death (N = 45) p-value 1
  Age, years 60.7 ± 11.9 60.0 ± 11.8 66.0 ± 12.0 0.002
  Gender, male 208 (56.2) 179 (55.1) 29 (64.4) 0.235
  Hemodialysis vintage, year 5.7 ± 4.9 5.9 ± 5.1 4.4 ± 2.9 0.060
  CCI 4.7 ± 1.6 4.6 ± 1.5 5.5 ± 1.6 <0.001
  PA, MET-min/wk 4964.9 ± 1871.9 5082.6 ± 1872.4 4114.2 ± 1651.4 0.001
  BMI, kg/m2 23.6 ± 3.9 23.6 ± 3.9 23.0 ± 3.5 0.348
Body composition
  FFM, kg 44.1 ± 11.1 44.0 ± 11.1 45.1 ± 9.1 0.507
  BFM, kg 17.9 ± 8.3 18.1 ± 8.5 16.4 ± 7.4 0.212
Laboratory parameters
  hs-CRP, mg/dL 0.25 (0.11–0.60) 0.24 (0.10–0.52) 0.52 (0.16–1.00) 0.003
  Hgb, g/dL 10.7 ± 1.1 10.8 ± 1.1 10.5 ± 1.3 0.174
  FBG (mg/dL) 132.3 ± 58.4 131.9 ± 59.0 135.5 ± 54.9 0.697
  Insulin, µU/mL 17.1 (8.8–31.7) 17.9 (9.0–32.3) 14.4 (7.2–28.0) 0.165
  TG (mg/dL) 159.6 ± 111.9 162.8 ± 115.2 136.3 ± 81.5 0.137
  HDL-C (mg/dL) 39.9 ± 22.0 39.3 ± 21.8 43.9 ± 23.1 0.204
  LDL-C, mg/dL 100.3 ± 31.7 101.1 ± 32.1 94.8 ± 28.2 0.212
  TC, mg/dL 165.6 ± 35.2 166.2 ± 35.0 160.9 ± 36.4 0.347
  Ca, mg/dL 9.3 (8.9 – 9.7) 9.3 (8.7–9.7) 9.3 (9.0–9.7) 0.463
  PO4, mg/dL 5.2 ± 1.2 5.2 ± 1.2 5.0 ± 1.3 0.381
  iPTH, pg/mL 254.0 (95.9–450.8) 266.5 (103.9–451.3) 139.4 (53.0–407.0) 0.063
  Hcy, µmol/L 20.7 ± 6.7 20.6 ± 6.6 21.2 ± 7.6 0.616
  Albumin, g/dL 4.0 ± 0.4 4.0 ± 0.4 3.9 ± 0.4 0.229
  Pre-BUN, mg/dL 72.8 ± 19.7 72.8 ± 20.2 73.4 ± 16.0 0.829
  Creatinine, mg/dL 11.1 ± 2.2 11.2 ± 2.2 10.2 ± 1.5 0.005
  K, mEq/L 4.8 (4.3–5.2) 4.8 (4.3–5.2) 4.8 (4.3–5.2) 0.876
  Uric acid, mg/dL 7.3 ± 1.3 7.3 ± 1.3 6.8 ± 1.2 0.009
  eKt/V 1.6 ± 0.3 1.6 ± 0.3 1.5 ± 0.2 0.038

CCI, Charlson comorbidity index; PA, physical activity; MET, metabolic equivalent minute/ week; BMI, body mass index; FFM, fat free mass; BFM, body fat mass; CRP, high-sensitivity C-reactive protein; Hgb, hemoglobin; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TC, total cholesterol; Ca, serum calcium; PO4, serum phosphate; iPTH, intact parathyroid hormone; Hcy, homocysteine; Pre-BUN, pre-dialysis blood urea nitrogen; K, serum potassium; eKt/V, equilibrated Kt/V (dialysis adequacy).1 Data was presented as mean ± SD, median (interquartile range), percentage for normal distributed, non-normal distributed continuous variables, and categorical variables, appropriately. p values were calculated to compare the distribution of patients’ characteristics, body composition, and biochemical parameters between the survival and the death, using independent-samples T test, Mann-Whitney U test, or Chi-square test, appropriately.